GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9 at 11:20 a.m. ET.
Live and replay webcasts will be available in the investor relations section of GRAIL's website for at least 30 days.
Positive
- None.
Negative
- None.
News Market Reaction – GRAL
In the May 27 session, GRAL gained 3.57%, reflecting a moderate positive market reaction. Argus tracked a peak move of +2.1% during that session. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 21 | Conference appearance | Neutral | -1.0% | Jefferies 2026 healthcare conference presentation announcement with webcast details. |
| May 5 | Earnings results | Positive | +15.3% | Q1 2026 revenue and Galleri growth update plus regulatory milestones. |
| Apr 30 | Conference appearance | Neutral | -0.8% | BofA 2026 health care conference presentation and webcast information. |
| Apr 22 | Earnings date notice | Neutral | -3.7% | Announcement of upcoming Q1 2026 results release and webcast timing. |
| Apr 21 | Clinical data update | Positive | +1.8% | Plan to present late-breaking NHS-Galleri and PATHFINDER 2 data at ASCO 2026. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Conference and scheduling announcements often saw flat-to-negative reactions, while fundamental or data-heavy updates tended to draw positive moves.
Over the past two months, GRAIL has mixed event-driven headlines with fundamental and clinical updates. Earnings on May 5, 2026 showed revenue growth and generated a +15.35% move, while ASCO trial data news on April 21 coincided with a +1.77% reaction. In contrast, announcements about upcoming conferences and earnings dates on April 22, April 30, and May 21 saw modest negative price moves, suggesting routine appearances have not been strong catalysts.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html
SOURCE GRAIL, Inc.